Research

Johns Hopkins Kimmel Cancer Center Immunotherapy Experts Named Bloomberg~Kimmel Professors

Posted by  | Research

Three Johns Hopkins Kimmel Cancer Center researchers were recognized as the first Bloomberg~Kimmel professors in cancer immunology during a ceremony at Johns Hopkins. The event marked the beginning of the Bloomberg~Kimmel Professorships program, and the three scientists were recognized for their work in precision immunotherapy, the bacterial contributions in the microbiome, and how targeting the(...)

Researchers Advance Role of Circulating Tumor DNA to Detect Early Melanoma Growth, Uncover Treatment Options

Posted by  | Research, treatment

Researchers at the Johns Hopkins Kimmel Cancer Center say they have added to evidence that measuring and monitoring tumor DNA that naturally circulates in the blood of melanoma patients can not only reliably help reveal the early stages of cancer growth and spread but also uncover new treatment options that tumor genetic analysis alone may(...)

NSCLC Treatment Gets Specific with Next-Gen Sequencing, Cell-Free DNA

Posted by  | Research

During a presentation on advanced non-small cell lung cancer (NSCLC), Ben Levy, M.D., a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, said there is a new opportunity for clinicians to be more specific when targeting mutations in those cancer patients.(...)

Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer

Posted by  | Issues & Perspectives, Research, Survivorship

Julie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, her research and clinical practice focuses on the development of new therapies for the treatment and prevention(...)

Washington Post Cancer Summit: A Silent Epidemic: The rise of HPV-related cancers

Posted by  | Issues & Perspectives, Prevention/Screening, Research

Akila Viswanathan, M.D., executive vice chair of Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, was part of a panel discussion on the rise of HPV-related cancers. The panel was just one section of the Washington Post Cancer Summit. Viswanathan was joined by other experts in taking look at rising HPV-related cancer rates in the(...)

Special Delivery Targets Brain Cancer Cells

Special Delivery Targets Brain Cancer Cells

Posted by  | Research

Pictured: Nanoparticles releasing microRNAs inside a brain cancer cell. Johns Hopkins Kimmel Cancer Center brain cancer researchers announced that they successfully delivered ultra-tiny nano-size packets of genetic code, called microRNAs, in animal models of human brain cancer. This multi-specialty study was led by John Laterra, M.D., Ph.D., co-director of the Kimmel Cancer Center Brain Cancer(...)

A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet

A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet

Posted by  | Issues & Perspectives, Patient Stories, Prevention/Screening, Research, treatment

Read the latest issue of Promise & Progress featuring research advances in cancer drug discovery and development, promising new cancer drugs, patient stories and more. From scientific meetings to our own dinner tables, conversations about better treatments for cancer are among the most frequently discussed health care topics. Everyone wants them—the doctors and scientists who(...)

Jaffee to Lead AACR; Conference Focuses on Innovative Cancer Science

Jaffee to Lead AACR; Conference Focuses on Innovative Cancer Science

Posted by  | Research

Driving innovative cancer science to patient care is the theme for this year’s American Association for Cancer Research annual meeting in Chicago. As more progress against cancer emerges from various areas of study, scientists are bringing different tools and skills together to help diagnose cancer at an earlier stage, increasing the chances of effective treatment(...)

Remembering Dr. Richard Humphrey, Multiple Myeloma Pioneer

Remembering Dr. Richard Humphrey, Multiple Myeloma Pioneer

Posted by  | Research, Uncategorized

Richard Humphrey, a multiple myeloma pioneer who was among our founding Cancer Center faculty members and former director of its diagnostic immunology laboratory, died on March 27, 2018. Dr. Humphrey reflected on the early years of the “Oncology Center” on its 25th anniversary: “Mighty oaks from tiny acorns grow. Who would have predicted that such(...)